| LTUQX | RMAGX | LTUQX / RMAGX | |
| Total Expense Ratio | 1.32 | 0.26 | 508% |
| Annual Report Gross Expense Ratio | 3.52 | 0.26 | 1,354% |
| Fund Existence | 6 years | 16 years | - |
| Gain YTD | 0.136 | -0.749 | -18% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000 | 250 | 2,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 75.9M | 13B | 1% |
| Annual Yield % from dividends | 2.41 | 4.58 | 53% |
| Returns for 1 year | 2.40 | 2.78 | 86% |
| Returns for 3 years | 12.77 | 15.75 | 81% |
| Returns for 5 years | 2.06 | 2.31 | 89% |
| Returns for 10 years | N/A | 11.78 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 42.26 | 0.60 | +1.44% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| PHSYX | 77.79 | 0.93 | +1.21% |
| Putnam Global Health Care Y | |||
| BASAX | 21.38 | 0.07 | +0.33% |
| Brown Advisory Small-Cap Growth Adv | |||
| JARIX | 16.25 | 0.02 | +0.12% |
| Easterly Global Real Estate I | |||
| UTEN | 42.34 | -0.11 | -0.27% |
| F/m US Treasury 10 Year Note ETF | |||